Ondine Biomedical, Inc. (GB:OBI) has released an update.
Ondine Biomedical Inc. has announced that Mater Hospital in Sydney is the first in Australia to adopt its Steriwave technology, which aims to reduce hospital-acquired infections using light-activated antimicrobial treatment. A study presented at the Spine Society of Australia meeting showed Steriwave significantly decreases surgical site infections and offers substantial cost savings per patient. The company is at the forefront of developing non-antibiotic methods for pathogen decolonization, backed by global health guidelines.
For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.
